Max-Delbrück-Centrum für molekulare Medizin (MDC) Berlin-Buch
发明人:
Blankenstein, Thomas,Willimsky, Gerald
申请号：
AU2020200092
公开号：
AU2020200092A1
申请日:
2020.01.07
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
#$%^&*AU2020200092A120200130.pdf#####ABSTRACT The present invention relates to a method for the production of novel T-cell receptors (TCR) which provide a reduced risk of adverse events in immune therapy, specifically in adoptive T cell transfer. The TCRs produced according to the method of the invention are specific for tumor cells and do not react with healthy tissue. Furthermore provided are nucleic acids encoding the TCR of the invention, vectors and host cells comprising the TCRs of the invention as well as their use is the treatment of tumorous diseases.
